Skip to main content
NCBI home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;5(4):367–377. doi: 10.1111/j.1582-4934.2001.tb00171.x

Prion diseases: contribution of high‐resolution immunomorphology

J‐G Fournier 1,✉, V Grigoriev 1,2
PMCID: PMC6740125  PMID: 12067470

Abstract

The transmisible spongiform encephalopathies or prion diseases are fatal neurological diseases that occur in animals and humans. They are characterized by the accumulation in the cerebral tissue of the abnormal form of prion protein (PrPsc) produced by a post‐translational event involving conformational change of its normal cellular counterpart (PrPc). In this short review, we present some results on the biology of prion proteins which have benefited from morphological approaches combining the electron microscopy techniques and the immunodetection methods. We discuss data concerning in particular the physiological function of the normal cellular prion prion (PrPc) which have allowed to open up new vistas on prion diseases, the biogenesis of amyloid plaque and the cellular site involved in the prion protein conversion process.

Keywords: immunoelectron microscopy, prion proteins, synapse, lysosomes, amyloid plaques, prion diseases

References

  • 1. Gajdusek D. C., Unconventional viruses and the origin and disappearance of kuru. Science 197, 943–960, 1977. [DOI] [PubMed] [Google Scholar]
  • 2. Prusiner S. B., Prions. Proc. Natl. Acad. Sci. U S A. 95: 13363–13383, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Büeler H., Aguzzi A., Saile A., Greiner RA., Autenried P., Aguet M., Weissmann C., Normal development and behaviour of mice lacking the neuronal cell‐surface PrP protein. Cell, 73: 1339–1347, 1993. 8100741 [Google Scholar]
  • 4. Prusiner S. B., Molecular biology of prion diseases. Science, 252: 1515–1522, 1991. [DOI] [PubMed] [Google Scholar]
  • 5. Brown H. R., Goller N., Rudelli G., Wolfe G. C., Wisniewski H. M., Robakis N. K., The mRNA encoding the scrapie agent protein is present in a variety of non‐neuronal cells. Acta Neuropath. 80: 1–6, 1990. [DOI] [PubMed] [Google Scholar]
  • 6. Fournier J. G., Nonneuronal cellular prion protein. Int. Rev. Cytol., 2001. [DOI] [PubMed]
  • 7. Caughey B., Raymond G. J., The scrapie‐associated form of PrP is made from a cell surface precursor that is both protease and phopholipase sensitive. J. Biol. Chem. 266: 18217–18223, 1991. [PubMed] [Google Scholar]
  • 8. Harris D., Cellular biology of prion diseases. Clin. Microbiol. Review 12, 429–444, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Caughey B., Raymond G. J., Ernst D., Rac, R. E. , N‐terminal truncation of the scrapie‐associated form of PrP by lysosomal protease(s), implications regarding the site of conversion of PrP to the protease‐resistant sate. J. Virol. 65: 6597–6603, 1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Wiley C. A., Burrola P. G., Buchmeier M. J., Wooddell M. K., Barry R. A., Prusiner S. B., Immunogold localization of prion filaments in scrapieinfected hamster brain. Lab. Invest. 57: 646–656, 1987. [PubMed] [Google Scholar]
  • 11. Bendheim P. E., Brown H. R., Rudelli R. D., Scala. J. Goller, N. L. , Wen G. Y., Kascsak R. J., Cashman N. R., Bolton D. C., Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42, 149–156, 1992. [DOI] [PubMed] [Google Scholar]
  • 12. Fournier, J. G , and Escaig‐Haye, F. , In situ Molecular hybridization techniques for ultra‐thin sections In Hajibagheri M. A., (ed): Electron Microscopy, Methods and protocols. Methods in Molecular Biology. Humana Press, Totawa 1999, pp. 167–182. [DOI] [PubMed] [Google Scholar]
  • 13. Fournier J. G., Escaig‐Haye F., Billette de Villemeur T., Robain, O. , Ultrastructural localization of cellular prion protein (PrPc) in synaptic boutons of normal hamster hippocampus. C. R. Acad. Sci. Paris 318: 339–344, 1995. [PubMed] [Google Scholar]
  • 14. Salès N., Rodolfo K., Hassig R., Faucheux B., Di Giamberardino L., Moya K. L., Cellular prion protein localization in rodent and primate brain. Eur. J. Neurosci. 10, 2464–2471, 1998. [DOI] [PubMed] [Google Scholar]
  • 15. Moya K. L., Sales N., Hassig R., Creminon C., Grassi J., Di Giamberardino L. Immunolocalization of the cellular prion protein in normal brain. Microsc. Res. Tech. 50, 58–65, 2000. [DOI] [PubMed] [Google Scholar]
  • 16. Haeberlé A., Ribaut‐Barassin C., Bombarde G., Mariani J., Hunsmann G., Grassi J., Bailly, Y. , Synaptic prion protein immuno‐reactivity in the rodent cerebellum. Microsc. Res. Tech. 50, 66–75, 2000. [DOI] [PubMed] [Google Scholar]
  • 17. Fournier J. G., Escaig‐Haye F., Grigoriev V., Ultrastructural localization of prion proteins: Physiological and pathological implications. Microsc. Res. Tech. 50, 76–88, 2000. [DOI] [PubMed] [Google Scholar]
  • 18. Keshet G. I., Bar‐Peled O., Yaffe D., Nudel U., Gabizon R., The cellular prion protein colocalizes with the dystroglycan complex in the brain. J. Neurochem. 75: 1889–1897, 2000. [DOI] [PubMed] [Google Scholar]
  • 19. Spielhaupter C, Schatzl HM., PrPC Directly Interacts with Proteins Involved in Signaling Pathways. J. Biol. Chem. 76: 44604–44612, 2001. [DOI] [PubMed] [Google Scholar]
  • 20. Waggoner D. J., Drisaldi B., Bartnikas T., Casareno L., Prohaska J., Gitlin J., Harris, D. , Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275: 7455–7458, 2000. [DOI] [PubMed] [Google Scholar]
  • 21. Kretzschmar H. A, Tings T., Madlung A., Giese A., Herms J., Function of PrP(C) as a copper‐binding protein at the synapse. Arch. Virol. Suppl. 16: 239–249, 2000. [DOI] [PubMed] [Google Scholar]
  • 22. Brown D. R., Prion and prejudice: normal protein and the synapse. Trends Neurosci. 24: 85–90, 2001. [DOI] [PubMed] [Google Scholar]
  • 23. Gauczynski S., Peyrin J. M., Haik S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J. P., Dormont D., Lasmezas C. I., Weiss S., The 37‐kDa/67‐kDa laminin receptor acts as the cell‐surface receptor for the cellular prion protein. EMBO J. 20: 5863–75, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Herms, J. , Tings, T. , Gall, S. , Madlung, A , Giese, A. , Siebert, H. , Schurmann, P. , Windl, O. , Brose, N. , and Kretzschmar, H. , Evidence of presynaptic localization and function of the prion protein. J. Neurosci. 19, 8866–8875, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Gohel C., Grigoriev V., Escaig‐Haye F., Lasmezas C. I., Deslys J. P, Langeveld J., Akaaboune M., Hantai D., Fournier J. G., Ultrastructural localization of cellular prion protein (PrPc)at the neuromuscular Junction. J. Neurosci. Res. 55: 261–267, 1999. [DOI] [PubMed] [Google Scholar]
  • 26. Fournier, J. G. , Escaig‐Haye, F. , Billette de Villemeur, T. , Robain, O. , Synaptic aspects of cellular prion protein In: Festoff B., Hantai D., Citron B. A., eds., Advances in Organ Biology, vol2, JAI Press INC., Connecticut , Greenwich , 1997, pp. 99–111. [Google Scholar]
  • 27. Carleton A., Tremblay P., Vincent J. D., Lledo P. M., Dose‐dependent, prion protein (PrP)‐mediated facilitation of excitatory synaptic transmission in the mouse hippocampus, Pflugers Arch. 442: 223–229, 2001. [DOI] [PubMed] [Google Scholar]
  • 28. Fournier J. G., Escaig‐Haye F., Billette de Villemeur T., Robain, O. , Lasmezas C. I., Deslys J. P., Dormont, D. , Brown, P. , Distribution and submicroscopic immunogold localization of cellular prion protein (PrPc) in extracerebral tissues. Cell Tissue Res. 22: 77–84, 1998. [DOI] [PubMed] [Google Scholar]
  • 29. Bolton D. C., Prion distribution in hamster lung and brain following intraperitoneal inoculation. J. Gen. Virol. 79, 2557–2562, 1998. [DOI] [PubMed] [Google Scholar]
  • 30. Ikeda K., Kawada N., Wang Y. Q., Kadoya H., Nakatani K., Sato M., Kandea K., Expression of cellular prion protein in activated hepatic stellate cells. Am. J. Pathol. 153, 1695–1700, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Kitamoto T., Shin R. W., Doh‐ura K., Tomokane N., Miyazono M., Muramoto T., Tateishi J., Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt‐J. akob disease. Am. J. Pathol. 140: 1285–1294, 1992. [PMC free article] [PubMed] [Google Scholar]
  • 32. Grigoriev V. B., Escaig‐Haye F., Streichenberger N., Kopp N., Langeveld J., Brown P., Fournier J‐G., Submicroscopic immunodetection of PrP in the brain of a patient with a new‐variant of Creutzfeldt‐Jakob disease. Neurosci. Lett. 263: 59–63, 1999. [DOI] [PubMed] [Google Scholar]
  • 33. Clinton J., Forsyth C., Royston M. C., Roberts G. W., Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. NeuroReport 4: 65–68, 1993. [DOI] [PubMed] [Google Scholar]
  • 34. Vorberg I., Chan K., Priola S. A.. Deletion of betastrand and alpha‐helix secondary structure in normal prion protein inhibits formation of its protease‐resistant. J Virol. 75: 10024–32, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Arnold J. E., Tipler C., Laslo L., Hope J., Landon M., Mayer R. J., The abnormal isoform of the prion protein accumulates in late‐endosome‐like organelles in scrapie‐infected mouse brain. J. Pathol. 176: 403–411, 1995. [DOI] [PubMed] [Google Scholar]
  • 36. Merz P. A., Kascsak R. J., Rubenstein R., Carp R. I, Wisniewski H. M., Antisera to scrapie‐associated fibril protein and prion protein decorate scrapie‐associated fibrils, J. Virol. 61: 42–49, 1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Mc Kinley M. P., Taraboulos A., Kenaga L., Serban D., Steiber A., DeArmond S. J., Prusiner S. B., Gonatas N., Ultrastructural localization of scrapie prion proteins in cytolasmic vesicles of infected cultured cells. Lab invest 65: 622–630, 1991. [PubMed] [Google Scholar]
  • 38. Jeffrey M., Goodsir C., Bruce M. E., Mc Bride P. A., Faquhar C., Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropath. App. Neurobiol. 20: 535–542, 1994. [DOI] [PubMed] [Google Scholar]
  • 39. DeArmond S. J., Mc Kinley M. P., Barry R. A., Braunfeld M. B., Mc Colloch J. R., Prusiner S. B., Identification of prion amyloid filaments in scrapieinfected brain. Cell 41: 221–235, 1985. [DOI] [PubMed] [Google Scholar]
  • 40. Wiley C. A., Burrola P. G., Buchmeier M. J., Wooddell M. K., Barry R. A., Prusiner S. B., Immunogold localization of prion filaments in scrapie‐infected hamster brain. Lab. Invest. 57: 646–656, 1987. [PubMed] [Google Scholar]
  • 41. Doerr‐Schott J., Kitamoto T., Tateishi J., Boellaard J. W., Heldt N., Lichte C., Immunogold light and electron microscopic detection of amyloid plaques in transmissible spongiform encephalopathies. Neuropath. Appl. Neurobiol. 16: 85–89, 1990. [DOI] [PubMed] [Google Scholar]
  • 42. Giaccone G., Verga L., Bugiani O., Frangione B., Serban D., Prusiner S. B., Farlow M. R., Ghetti B., Tagliavini F., Prion protein preamyloid and amyloid deposits in Gerstmann‐Straussler‐Scheinker disease, Indiana kindred. Proc. Natl. Acad. Sci. U S A, 89: 9349–9353, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Ironside J. W., Head M. W., Bell J. E., McCardle L., Will R. G., Laboratory diagnosis of variant Creutzfeldt‐Jakob disease. Histopathology, 37: 1–9, 2000. [DOI] [PubMed] [Google Scholar]
  • 44. Chazot G., Broussolle E., Lapras C. I., Blattle, T. , Aguzzi A., Kopp N., New variant of Creutzfeldt‐J. akob disease in a 26‐year‐old French man. Lancet 347: 1181, 1996. [DOI] [PubMed] [Google Scholar]
  • 45. Fournier J. G, Kopp N Streichenberger N, Escaig‐Haye F, Langeveld J., Brown P., Electron microscopy of brain amyloid plaques from a patient with a new variant Creutzfeldt‐Jakob disease. Acta Neuropath. 96: 637–642, 2000. [DOI] [PubMed] [Google Scholar]
  • 46. Jeffrey M., McGovern G, Goodsir CM, Brown KL, Bruce ME., Sites of prion protein accumulation in scrapie‐infected mouse spleen revealed by immuno‐electronmicroscopy. J. Pathol. 191: 323–32, 2000. [DOI] [PubMed] [Google Scholar]
  • 47. Grigoriev V., Adjou K., Salès N., Simoneau S., Deslys J. P., Seman M., Dormont D., Fournier J. G., Effects of the polyene antibiotic derivative MS‐8209 on the astrocyte lysosomal system of scrapie‐infected hamsters J Mol. Neurosc. 2001. [DOI] [PubMed]
  • 48. Mayer R. J., Landon M, Laszlo L, Lennox G, Lowe J., Protein processing in lysosomes: The new therapeutic target in neurodegenerative disease. Lancet 340: 156–159, 1992. [DOI] [PubMed] [Google Scholar]
  • 49. Stinchcombe J. C., Griffiths G. M., Regulated secretion from hemopoietic cells. J. Cell Biol. 147: 1–6, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Doh‐Ura K., Iwaki T., Caughey B., Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie‐associated prion protein accumulation. J. Virol. 74: 4894–4897, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES